
About Orange Pharma Private Limited
Data last updated:
Orange Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC124440.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunaina Jain and Kuldeep Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orangepharma.com.
Company details
Contact details
Orange Pharma Private Limited's registered office is in Delhi, Delhi. Its website is orangepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressN – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Orange Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Orange Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Orange Pharma Private Limited, buy the company report.
Financials of Orange Pharma Private Limited
FY 2025 filings availableOrange Pharma Private Limited reported revenue of ₹7,100 (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 24%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orange Pharma Private Limited, buy the company report.
Board of directors of Orange Pharma Private Limited
Orange Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunaina Jain Also directs: Nordea Lifescience Private Limited | Director | 25 Aug 2009 | 17 Years 2 Months | Current |
| Kuldeep Jain Also directs: Nordea Lifescience Private Limited, Sara Biotique Private Limited | Director | 04 Feb 2004 | 22 Years 9 Months | Current |
Auditor
Orange Pharma Private Limited is audited by MANISH S GOEL & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH S GOEL & ASSOCIATES | FY 2016 | 019894N |
Shareholding
The shareholding of Orange Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Orange Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orange Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orange Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Orange Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orange Pharma Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Sunaina Jain ceased to be Additional Director on 30 Sep 2009.
Frequently asked questions
Orange Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2004 (22+ years old) and is registered under CIN U24239DL2004PTC124440.
Orange Pharma has 2 current directors:
- Sunaina Jain - Director
- Kuldeep Jain - Director
The latest financial statements of Orange Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Orange Pharma is U24239DL2004PTC124440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orange Pharma was incorporated on 04 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Sunaina Jain ceased to be Additional Director on 30 Sep 2009. Rajeev Jain ceased to be Director on 28 Aug 2009. Sunaina Jain was appointed as Director on 25 Aug 2009. Orange Pharma has 4 board changes on record in total.
Orange Pharma can be reached through the website orangepharma.com. Its registered office is in Delhi, India.
The registered office of Orange Pharma is at N – 37 Sector 5 Dsidc Industrial Area Bawana, Delhi, India – 110039.
Orange Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Orange Pharma is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

